Author:
Israel Ora,Delbeke Dominique
Reference62 articles.
1. Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: Potential for error in interpretation. Semin Nucl Med 1996;26:308–314.
2. Engel H, Steinert H, Buck A, Berthold T, Boni RAH, von Schulthess GK. Whole body PET: Physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441–446.
3. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 1998;28:352–358.
4. Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG, Jeong S-Y, Kim SW. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. Clin Endocrinol Metab 2003;88:4100–4104.
5. Israel O, Weiler-Sagie M, Rispler S, Bar-Shalom R, Frenkel A, Keidar Z, Bar-Shalev A, Strauss HW. PET/CT quantitation of the effect of patient-related factors on cardiac 18F-Fluoro-deoxyglucose uptake. J Nucl Med 2007;48:234–239.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献